GNB5 and Alzheimer disease: Additionally, while Gnb5 itself may not be an ideal druggable target as a G protein subunit, its effectiveness in reducing Aβ load and improving cognitive performance in AD mouse models highlights the potential of targeting regulators upstream or downstream in Gnb5-signaling pathways.